Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06907667

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure - CHRONOVAX 2

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
735 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Immune response to influenza vaccine in patients with chronic renal insufficiency.

Detailed description

Seasonal influenza vaccination is recommended for patients with chronic renal insufficiency, as influenza is responsible for significant morbidity and mortality in this immunocompromised population. However, the immune response to this vaccination is limited in this population. There are currently no recommendations concerning the timing of influenza vaccine in the general population or in immunocompromised patients. In this context, recent studies have shown that the time of vaccination can have an impact on vaccine efficacy. This is the case for BCG, influenza and COVID vaccinations. On this basis, our main hypothesis is that the administration of influenza vaccine to patients with chronic kidney failure is more effective in the morning than in the evening.

Conditions

Interventions

TypeNameDescription
OTHERVaccine injectionInjection of the vaccine in chronic renal insufficiency patients.

Timeline

Start date
2025-09-03
Primary completion
2026-03-01
Completion
2026-09-01
First posted
2025-04-02
Last updated
2025-09-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06907667. Inclusion in this directory is not an endorsement.